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BACKGROUND: The essential aetiology of radiation-induced acute myeloid leukaemia (AML) in mice is the downregulation of the
transcription factor PU.1. The causative mutation of the PU.1-endocing Sfpi1 gene consists mostly of C:G to T:A transitions at a CpG
site and is likely to be of spontaneous origin. To work out a mechanism underlying the association between radiation exposure and
the AML induction, we have hypothesised that replicative stress after irradiation accelerates the ageing of haematopoietic stem cells
(HSCs), and the ageing-related decline in DNA repair could affect the spontaneous mutation rates.
METHODS: Mathematical model analysis was conducted to examine whether and to what extent the cell kinetics of HSCs can be
modified after irradiation. The haematopoietic differentiation process is expressed as a mathematical model and the cell-kinetics
parameters were estimated by fitting the simulation result to the assay data.
RESULTS: The analysis revealed that HSCs cycle vigourously for more than a few months after irradiation. The estimated number of cell
divisions per surviving HSC in 3Gy-exposed mice reached as high as ten times that of the unexposed.
INTERPRETATION: The mitotic load after 3Gy irradiation seems to be heavy enough to accelerate the ageing of HSCs and the
hypothesis reasonably explains the leukaemogenic process.
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There is substantial evidence that ionising radiation can cause
various types of malignancies. Among them, leukaemia is
noteworthy because of the high relative risk and the short latency
(Preston et al, 1994). The mechanism of radiation leukaemogen-
esis, however, is not yet fully explained despite recent advances in
the understanding of genetic alterations in leukaemic cells. It has
been speculated that leukaemia-specific gene rearrangements
(Schoch and Haferlach, 2002; Mro ´zek et al, 2004) are attributable
to the misrepair of initial DNA damage caused by radiation. This
notion, however, suffers from the low probability of such events
given the random nature of radiation-induced DNA damage. It is
also difficult to rationalise the latency period for the disease.
Radiation-induced delayed gnomic instability could explain the
leukaemogenic process more plausibly, but there is no conclusive
evidence of its involvement (Morgan, 2003). The findings of
healthy carriers of leukaemia-specific gene rearrangements have
lead to a further bold hypothesis that only those carriers are at
risk for developing leukaemia when exposed to radiation
(Nakamura, 2005).
Radiation-induced acute myeloid leukaemia (AML) in some
strains of mice serves as a well-established animal model to explore
this issue. The incidence increases with doses up to 3Gy and the
symptoms of the affected mice are similar to those found in human
AML (Upton et al, 1958; Major, 1979; Mole et al, 1983; Resnitzky
et al, 1985; Seki et al, 1991). The leukaemic cells usually carry a
deletion of chromosome 2 (Hayata et al, 1983; Trakhtenbrot et al,
1988; Rithidech et al, 1993; Clark et al, 1996) and a mutation of the
Sfpi1 gene on the retained homologue (Cook et al, 2004; Suraweera
et al, 2005; Hirouchi et al, 2008). These genetic changes result in
downregulation of the transcript PU.1, which is crucial for normal
myeloid differentiation (Cook et al, 2004). Although the Sfpi1
mutations are often accompanied by additional genetic alterations,
such as amplification of Myc (Rosenbauer et al, 2004; Hirouchi
et al, 2008), studies with genetically engineered mice show that
downregulation or inactivation of PU.1 is sufficient to induce AML
(Rosenbauer et al, 2004; Metcalf et al, 2006). Therefore, radiation is
considered to be responsible for either or both of two genetic
events, the deletion of chromosome 2 and the mutation of Sfpi1.
Several studies have provided circumstantial evidence that
radiation can induce AML-type deletions of chromosome 2
(Hayata, 1985; Trakhtenbrot et al, 1988; Ban et al, 1997; Peng
et al, 2009), even though it is inconclusive whether the aberrations
arise as a consequence of initial DNA damage or through delayed
chromosomal instability (Plumb et al, 1998; Bouffler et al, 2001;
Boulton et al, 2001). As for the mutation of Sfpi1, however, there is
no direct data about the involvement of radiation in its induction.
The Sfpi1 mutations found in AMLs are mostly point mutations at
codon 235 of the DNA-binding Ets domain. The majority of them
are C:G to T:A transitions at a CpG site (Cook et al, 2004;
Suraweera et al, 2005; Hirouchi et al, 2008), the most common type
of spontaneous mutations (Douglas et al, 1994; Ushijima et al,
1994). In the case of radiation-induced mutations, large-scale
deletions are most frequent (Thacker, 1986; Sankaranarayanan,
1991). Point mutations might predominate among late-arising
mutations (Little, 2000), but transversions rather than transitions
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sare expected given that oxidative stress-related genotoxicity
directly contributes to those mutations (Wright, 1998; Busuttil
et al, 2003). For these reasons, the Sfpi1 mutations of murine AML
are likely to be of spontaneous origin.
Normal cells equipped with various forms of repair machinery
can replicate and maintain DNA with great accuracy. Nevertheless,
DNA is damaged and mutated on repeated replications. This is the
case even in haematopoietic stem cells (HSCs) because they
accumulate DNA damage after repeated rounds of replications and
those mutations are associated with stem cell ageing (Kamminga
and de Haan, 2006; Sharpless and DePinho, 2007). With evidence
of decline in HSC functional capacity among mice deficient in
DNA repair or telomere maintenance, accumulation of DNA
damage is postulated to be a cause of stem cell ageing (Rossi et al,
2007). At the same time, the mutation accumulation would be
accelerated as the cells age because HSCs from old wild-type mice
show the decreased expression of DNA repair and maintenance
genes (Chambers et al, 2007). The aged, damaged stem cells
eventually lose repopulating capability and stem cell function, but
they continue to proliferate with compromised genomic integrity if
they could escape extinction. In this regard, early studies on
haematopoietic effects of radiation present intriguing data. The
frequency of CFU-S is depressed while the level of cycling is
increased over the lifespan of x-irradiated mice (Tejero et al, 1988;
Lorimore and Wright, 1990). If HSCs also cycle at enhanced rates
for a prolonged period of time, the replicative stress will result in
premature ageing. The aged stem cells would show a decline
in DNA damage repair capacity and are prone to spontaneous
mutations.
In this study, we have used a mathematical model analysis to
examine whether and to what extent radiation cause replicative
stress in HSCs. The differentiation process of haematopoietic cells
was expressed in a mathematical model. The cell-kinetics
parameters were estimated by fitting the simulation result to the
experimental data of CAFC (cobblestone area forming cell) and
CFU-G/M (colony forming unit-granulocyte/macrophage) assays.
The analysis showed the upregulated cell kinetics for HSCs, which
seemed to be sufficient to accelerate ageing of them. Possible
leukaemogenic processes have been discussed based on the results,
and we have found the most plausible explanation is that the
replicative stress-related stem cell ageing plays a role elevating
spontaneous mutation rates of HSCs and their progeny.
MATERIALS AND METHODS
Model structure
Figure 1 illustrates the hierarchy of haematopoietic cells. Although
various assay techniques have been developed to measure the
frequencies of those cells, the assay data do not necessarily
represent the single cell types in the figure. For example, cycling
HSCs are not identified as LT-HSC owing to the cell-cycle
dependent decline in engraftment ability (Habibian et al, 1998;
Passegue ´ et al, 2005; Bowie et al, 2006). There are also transient or
fuzzy states between cell types. Applying a linear reservoir model
cannot demonstrate massive cell growth through the differentia-
tion process unless unrealistic parameters are assumed. These facts
indicate that a simulation with a straightforward modelling of the
hierarchy shown in Figure 1 is hard to verify experimentally.
To overcome these problems without compromising scientific
exactitude, we have constructed a mathematical model of myelo-
monocytic haematopoiesis as shown in Figure 2. In this model,
HSCs are divided into quiescent HSCs and cycling HSCs. The
former are LT-HSCs in G0 phase, which can be quantified by a
repopulation assay such as day-28 CAFC. Multipotent progenitor
(MPP) in Figure 2 represents ST-HSC and MPP in a limited sense.
Both have transient in vivo multilineage potential and are thought
to share similar cell kinetics. Day-14 CAFC can be an indicator of
these cell types as well as cycling HSCs (Ploemacher et al, 1991).
Common myeloid progenitor (CMP) is equivalent to CFU-GEMM
and GMP includes CFU-GM, CFU-G, and CFU-M. The ordinary
CFU-G/M assay, therefore, gives a measure of those cells. Each cell
compartment has a recurrent flow (self-renewal activity), but only
HSCs are presumed to be capable of complete replenishment.
Mathematical description
In Figure 2, quiescent HSCs recruited into the cell cycle (cycling
HSCs) self-renew or differentiate into MPPs. In the case of self-
renewal, the HSC returns to the quiescent state or continues to
cycle. As self-renewal and differentiation of cells take place on
mitoses, these processes are described by ordinary differential
equations with respect to time as
.
N1 ¼ r1N1 þ 2P21r2N2
.
N2 ¼ r1N1   r2N2 þ 2P22r2N2
where N1 is the number of quiescent HSCs, N2 the number of
cycling HSCs, r1 the rate of a quiescent HSC transferring to the cell
cycle, r2 the mitotic rate of cycling HSCs, P21 the probability of a
self-renewed HSC returning to the quiescent state, and P22 the
probability of a self-renewed HSC continuing to cycle.
Multipotent progenitor is a progeny of HSC and produces two
types of progenitors, common lymphoid progenitor and CMP. The
rate of change of MPP frequency is then written as
.
N3 ¼ 2P23r2N2   r3N3 þ 2P33r3N3
LT-HSC
ST-HSC
MPP
CLP CMP
MEP GMP
Granulocyte Macrophage Erythrocyte Platelet B cell T cell
Figure 1 Hierarchy of haematopoietic cells. Long-term reconstituting
haematopoietic stem cells (LT-HSCs) are the source of all blood-cell
lineages. Subsequent short-term reconstituting stem cells (ST-HSCs) have a
limited self-renewal activity and give rise to multipotent progenitors (MPPs).
MPPs produce common lymphoid progenitors (CLPs) and common
myeloid progenitors (CMPs). CMPs further differentiate into megakaryo-
cyte/erythroid progenitors (MEPs) and granulocyte/macrophage progeni-
tors (GMPs).
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swhere N3 is the number of MPPs, r3 the mitotic rate of MPP, P23 the
probability of an HSC differentiating into MPP, and P33 the self-
renewal probability of MPP (o0.5). Temporal variations of CMPs
and GMPs can be described in the same manner.
Simulation of haematopoiesis
Parameter values used in the simulation are summarised in
Table 1. The steady-state condition was assumed in unexposed
mice and the values of r were estimated from literature data of
BrdU incorporation in vivo (Bradford et al, 1997; Sudo et al, 2000;
Passegue ´ et al, 2005). The branching probability P for the self-
renewal of each cell type was determined such that the equilibrium
stationary state demonstrates the average values of the CAFC assay
and the CFU-G/M assay in the unexposed mice. Other P-values
were calculated by the relational expressions in Table 1 (Spangrude
and Johnson, 1990). Details about the parameter values are given
in the Supplementary material.
The number of cells in each compartment in the stationary state
was calculated by assuming the population size of quiescent HSCs
in an adult mouse to be 1 10
4 (Eaves et al, 1997). The cell
numbers were multiplied by survival fractions to estimate the
number of surviving cells just after 3Gy x-irradiation. Survival
fractions for MRA [CFU-S-12], CFU-S-12, CFU-S-7, and CFU-C
were calculated by the linear-quadratic model of Meijne et al
(1991) and were applied to quiescent HSC, cycling HSC/MPP,
CMP, and GMP, respectively. The surviving cell numbers were set
as the initial values and the time course of the recovery was
simulated. Some parameters were modulated within realistic
ranges during the recovery. They are the parameters for HSCs,
the mitotic rate of MPP, and the self-renewal probability of CMP.
The other parameters were unchanged or followed the relational
expressions in Table 1.
Finally, the number of cell divisions of each cell type was
estimated based on the simulation result. Setting time to be 0 at
irradiation, the cumulative number of cell divisions in the ith cell
compartment until time t was calculated by the formula
Mi ¼
Z t
0
riNidt
with the mitotic rate ri and the number of cells Ni at time t.
All calculations were performed in R using the lsoda function of
the odesolve package.
CAFC and CFU-G/M assays
Male C3H/HeN mice were purchased from Japan Clea and
maintained under conventional conditions. At 8–10 weeks of
age, they were exposed to 3Gy of 200kV X-rays filtered with
0.5mm Cu and 0.5mm Al (dose rate 0.47Gymin
 1). The irradiated
mice as well as age-matched controls were killed at 30, 90, 150, and
300 days post irradiation and bone marrow cells were collected
from the femora. Animal experiments were performed with the
approval of the Research Ethics Committee of Oita University of
Nursing and Health Sciences in conformity with applicable laws
and regulations.
Quiescent HSC
N1
MPP
N3
CMP
N4
r1
P45
r3
P22
P34
P21
r4 P44
GMP
N5
r5 P55
Cycling HSC
N2
r2
P33
P23
Day-28
CAFC
Day-14
CAFC
CFU-G/M
CLP
MEP
Figure 2 Framework of mathematical model for myelomonocytic
haematopoiesis. HSCs that have long-term repopulating ability are mostly
in the G0 phase and these cells are denoted as quiescent HSCs. Quiescent
HSCs recruited into the cell cycle (cycling HSC) replenish themselves or
differentiate into MPPs, CMPs, and GMPs in sequence. Equivalent cells in
the assays are shown on the right side. N denotes the number of cells, r the
transfer/mitotic rate, and P the branching probability.
Table 1 Parameter values used in the simulation
Parameter Steady state
a Recovery phase
b References
c
r1 0.03 [/d] Variable Bradford et al (1997);
Sudo et al (2000)
r2 0.8 [/d] Variable Passegue ´ et al (2005)
r3 0.55 [/d] Variable Passegue ´ et al (2005)
r4 1.9 [/d] Passegue ´ et al (2005)
r5 2.5 [/d] Passegue ´ et al (2005)
P21 0.5 P22 Variable
P22 0.462 Variable
P23 1 P21 P22
P33 0.480
P34 0.5 (1 P33)
P44 0.457 Variable
P45 0.75 (1 P44) Spangrude and
Johnson (1990)
P55 0.320
aValues for the unexposed steady state.
bValues for 3Gy-exposed mice. Parameters
modulated in response to haematopoietic demands are denoted as ‘variable’.
cReferences for the values or the relational expressions. For details, see the
Supplementary material.
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suspended in a-MEM (Sigma-Aldrich, Irvine, UK) containing
12.5% foetal calf serum (ThermoTrace, Melbourne, Australia),
12.5% horse serum (ThermoTrace), 10
 5M hydrocortisone
(Sigma-Aldrich), 100Uml
 1 penicillin, and 100mgml
 1 strepto-
mycin (Sigma-Aldrich). The cells were overlaid on MC3T3-G2/PA6
stromal cells (provided by the RIKEN CELL BANK) grown in a
collagen-coated 96-well flat-bottom microplate (Nalge Nunc
International, Rochester, NY, USA). Six dilution steps of the
overlaid cells were made with 3-fold intervals from 1000 to 243000
cells in 150ml culture volume, and 16 wells were used for each
dilution. Cultures were maintained at 331C, 5% CO2, and fed
weekly by a half medium change. On days 14 and 28 of culture, the
wells were inspected for cobblestone areas with an inverted
microscope TMF (Nikon, Tokyo, Japan). A well was scored as
positive if it contained more than one cobblestone area that
comprised at least five phase-dark cells. The limdil function of the
statmod package for R was used to find the maximum likelihood
solutions of the frequencies of the CAFCs.
Part of the bone marrow cells from each mouse was used for the
CFU-G/M assay. The cells were diluted with IMDM (Sigma-
Aldrich) containing 2% foetal calf serum and were mixed
with methylcellulose medium MethoCult GF M3534 (StemCell
Technologies, Vancouver, Canada). Two dishes of the semi-solid
culture containing 1.5 10
4 bone marrow cells in 1.1ml were
prepared for each mouse and were incubated at 371C, 5% CO2.O n
day 10 of incubation, the number of colonies containing more than
50 cells was counted on an inverted microscope.
RESULTS
Frequencies of primitive haematopoietic cells
Figure 3 shows the results of CFU-G/M and CAFC assays. The
frequencies of CFU-G/M in the exposed mice are comparable to
the unexposed throughout the experimental period, indicating a
rapid recovery of the committed progenitors after irradiation.
With regard to the CAFC frequencies, data of day-14 cultures for
150 days post irradiation varied so much that the limdil function
failed to find maximum likelihood solutions. The day-14 CAFC
frequency was also not calculable for a mouse of the control group
for 30 days post irradiation because all wells were positive for the
cobblestone area. Despite these missing data, Figure 3 clearly
shows that the level of primitive CAFCs was suppressed for a few
months after exposure. Long-term suppression was remarkable in
day-28 CAFCs. The frequency fell down to a tenth of the normal
level at 90 days post irradiation and did not fully recover even at
300 days post irradiation.
Simulation of recovery after irradiation
In the simulation of the recovery process, we first tested for the
priority to generate downstream cells rather than self-renewal of
HSCs, that is, increasing the branching probabilities for HSCs
differentiating into MPPs. This was not effective even in the short
term, however, and just exhausted HSCs. Upregulating the
transfer/mitotic rates of HSCs and MPPs resulted in quick recovery
of CFU-G/M, but the frequency of HSCs was suppressed to a low
level at all times if the self-renewal probability of HSC was
unchanged. These results show that it is necessary to enhance the
self-renewal of HSCs before the committed progenitors are
restored. It is also noteworthy that the frequencies of committed
cells can vary drastically in response to a subtle change in HSC
kinetics, indicating that continuous, fine adjustments are required
for the parameters.
Figure 4 displays a simulation result that fits to the assay data.
Although the parameters are not determined uniquely, they need
to be modulated in a certain way to demonstrate the recovery
pattern observed in the experiment. A time course of the
parameter changes can be divided into three prominent phases
shown in the graph.
Phase I: HSCs and MPPs respond to haematopoietic demands
until CFUs-G/M are restored. The probability of HSC
self-renewal is increased. Transfer/mitotic rates of HSC
and MPP are high.
Phase II: Cell kinetics is downregulated to prevent the over-
growth of CFUs-G/M. The probability of the HSC self-
renewal is suppressed. Transfer/mitotic rates are
decreased, but still higher than the normal state.
Phase III: HSCs increase gradually whereas the CFU-G/M fre-
quency remains constant. The probability of the
HSC self-renewal is moderately increased, but CMP
self-renewal is suppressed. Mitotic rates of HSCs and
MPPs are gradually increased with time.
Estimation of the number of cell divisions after irradiation
The number of cell divisions in each cell compartment was
calculated in the course of the simulated recovery process. Figure 5
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Figure 3 Results of CFU-G/M and CAFC assays. Four mice were used for each experimental condition and the markers represent individual animals. Data
are missing for day-14 CAFC of 150 days post irradiation because maximum likelihood solutions were not obtained because of inconsistently varied data
(see main text for details).
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sshows the cumulative number of cell divisions with or without
irradiation. Although the slope of the curve increases for HSCs and
MPPs at phase III of the recovery, there were no striking
differences from the control group during 300 days after exposure.
However, less than 10% of HSCs survived on exposure to 3Gy
X-rays, meaning that surviving HSCs bear a high mitotic load
to achieve a comparable number of cell divisions as a whole.
This was showed by the percentage of cycling HSCs, which were
elevated just after irradiation and never returned to a normal level
(Figure 6A). The number of cell divisions per surviving HSC was
remarkably high in that condition, more than 10 times that from
unexposed mice (Figure 6B). By 300 days post irradiation,
surviving HSCs underwent five times the number of cell divisions
that are expected for HSCs from unexposed mice during their
entire lifespan, assuming a longevity of 2 years.
DISCUSSION
We used CAFC assay to get a measure of multipotent haemato-
poietic cells. The CAFC assay is validated in many applications
(e.g., Breems et al, 1994; Parmar et al, 2005) and is said to be more
robust than the widely used CFU assay in some conditions (Olesen
et al, 2002). Our assay result also demonstrates its robustness
showing small inter-individual variations and good agreement in
the estimated CAFC frequencies for the unexposed mice with
literatures (Ploemacher et al, 1989; de Haan et al, 1997). Although
the missing data points in Figure 3 may reflect a limitation of the
culture-based limiting dilution assay, the obtained data are
regarded reasonable and reliable. Together with the solid result
of the CFU-G/M assay, the experimental data provide a good basis
for the mathematical simulation.
In the experiment, day-14 CAFCs and day-28 CAFCs revealed
long-term suppression after irradiation, although CFUs-G/M
did not show noticeable changes. This is because committed cells
are preferentially restored to minimise their influence on
circulating blood cells, which are essential for life. The mathema-
tical simulation has showed a quick recovery of CFUs-G/M by
vigorously cycling HSCs and MPPs just after irradiation, but the
emergent situation settled down as the frequencies of committed
cells reached a normal level. Once CFUs-G/M were restored, their
frequency remained almost constant and the CAFCs started
recovering slowly. It is a contradictory situation where HSCs and
MPPs proliferate without affecting the frequencies of the progeny
cells. The simulation has found that this can only be achieved
by upregulating the kinetics of HSCs/MPPs gradually while
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triangle, day-14 CAFC; and cross, day-28 CAFC). ‘Variable’ parameters
were continuously modulated with time in the simulation. The time course
of the parameter changes can be divided into three prominent phases and
are shown above the graph (see main text for details).
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Figure 5 Cumulative number of cell divisions. The number of cell divisions in each cell compartment was calculated using parameter sets that produced
the simulation results shown in Figure 4.
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ssuppressing the self-renewal of committed progenitors. The
frequency of MPP is suboptimal in that condition even if the cells
cycle more rapidly than in the normal state. This indication is
consistent with the reported late effects of x-irradiation on CFU-S
(Lorimore and Wright, 1990). On the basis of cell kinetics
estimated by the simulation, the number of cell divisions of each
cell type was calculated. Despite the upregulated cell kinetics for
HSCs and MPPs, the cumulative number of cell divisions did not
show marked increases. This is because the enhanced proliferation
is almost offset by the lower number of cells than in the normal
state.
Given the number of cell divisions, it is possible to estimate the
spontaneous mutation frequency. Although spontaneous muta-
tions arise from various pathways during normal metabolism, they
are fixed through the DNA replication process. If one assumes a
constant mutation rate per cell division, mutational events in a cell
population follow poisson statistics. Mutation rates in eukaryotic
cells are generally p10
 10 mutations per base pair replicated per
generation (Kunkel and Bebenek, 2000). As the Sfpi1 mutations of
AMLs are confined to specific positions of exon 5 (Cook et al,
2004; Hirouchi et al, 2008), it is reasonable to presume the AML-
specific Sfpi1 mutations occur at the rate of up to 10
 9 per cell
division in normal cells.
Figure 7 shows the calculated probability of the AML-specific
mutational events in a 3Gy-exposed mouse for that condition.
During the 300 days after exposure, at most one or two mutational
events are expected in CMPs and GMPs, but practically zero in
HSCs and MPPs. Irradiated C3H/He mice develop AMLs with a
median latency of 450–500 days (Seki et al, 1991). In conditional
gene targeting, AMLs appear 23.5±6.2 weeks after the inactivation
of Sfpi1 (Metcalf et al, 2006). Taken together, a rough estimate
shows that a malignant cell has to appear by 300 days post
irradiation in about a half of leukaemia cases (410% of the 3Gy-
exposed mice). The calculated probability of the mutational events
is too low to explain AML induction in mice, considering that the
mutation of Sfpi1 has to coincide with the deletion of chromosome
2 to form the malignant cell.
There are some possible explanations that reconcile this
inconsistency. One is to reconsider the fundamental hypothesis,
presuming the mutation of Sfpi1 is a consequence of radiation
exposure. Mutation frequency of a single gene after 3Gy exposure
in vivo is estimated to be 10
 5–10
 4 based on an extrapolation
from high-dose data in lacZ transgenic mice (Nakamura et al,
2000). Although the value seems to be too small to explain the
AML incidence, the frequency could be higher if the relevant
chromosomal region has a special chromatin structure and is
vulnerable to extrinsic insults. Alternatively, it is possible to
suppose that the delayed genomic instability is responsible for the
mutagenesis (Morgan, 2003). In either case, the expected mutation
spectrum will be different from that found in AML mice as
mentioned earlier, but the discrepancy may be attributable to a
clonal selection of the mutants. Even so, however, it is unlikely that
very limited clones have a survival advantage because the Sfpi1
mutations required for the AML development are just an
inactivation of the gene. Evidence of a total gene deletion or
removal of exon 5 developing into the leukaemia (Silver et al, 1999;
Metcalf et al, 2006) implies the particular mutation pattern in the
AML mice is not a consequence of clonal selection.
Another possibility is that cells with hemizygous deletion
of chromosome 2 acquire a growth advantage and just one or
two spontaneous mutagenic events are enough with a large
population base of those cells. Haploinsufficiency for Sfpi1 can
bring phenotype alteration enhancing neutrophil progenitor
development, but the gene dosage effect is masked in vivo by
changes in cytokine expression (Dahl et al, 2003). In fact, clonal
analysis of the chromosomal aberrations in irradiated mice
indicates no apparent selective or proliferative advantage of
hemizygously deleted cells during 12 months after irradiation
(Bouffler et al, 1997).
The most plausible explanation will be to allow for the increase
in the mutation rate associated with the ageing of stem cells. Our
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ssimulation predicts that most of the surviving HSCs are recruited
into the cell cycle after 3Gy exposure, and that the percentage of
cycling HSCs remains at B60%. This contrasts with the cell
kinetics of HSCs in the steady state, in which two-thirds of the
population are quiescent. Owing to the increased cycling fraction,
together with the enhanced mitotic rate, the surviving HSCs in the
exposed mouse undergo the extensive rounds of replication. This
will make the cells senescent and the mutation accumulation
would be accelerated.
There is considerable evidence that continuous replicative stress
accelerates the ageing of stem cells, and that aged stem cells are
characterised by compromised genome maintenance. Serial
transplantation assays in mice have shown that forced stem
cell expansion results in deterioration of HSCs (Harrison et al,
1978, 1990; Ross et al, 1982; Spangrude et al, 1995). Functional
changes in deteriorated HSCs are comparable to those observed in
aged animals – a reduced repopulating ability and preferential
differentiation into myeloid lineages (Sudo et al, 2000; Kim et al,
2003). Enhanced proliferation of HSCs caused by gene knockouts
also leads to a decline of stem cell functions (Cheng et al, 2000;
Hock et al, 2004). Furthermore, a conditional knockout for the Atr
gene has showed that even homeostatic proliferation can promote
stem-cell dysfunction and ageing (Ruzankina et al, 2007). There-
fore, the excessive number of cell divisions in response to
haematopoietic demands after irradiation probably promotes
the ageing of surviving HSCs. A recent study by Chambers et al
has found that the gene expression profile changes as HSCs
age, and among the downregulated genes are those involved
in the preservation of genomic integrity, such as chromatin
remodelling and DNA repair (Chambers et al, 2007). A decline in
the expression of those genes will manifest as elevated mutation
rates.
We therefore propose a model for murine myeloid leukaemo-
genesis as shown in Figure 8. Radiation causes cell death of
progenitors and stem cells in the haematopoietic system. It also
induces chromosomal aberrations and some HSCs survive with a
deletion of chromosome 2, being hemizygous for the Sfpi1 gene.
When a substantial fraction of haematopoietic cells are killed
by radiation, surviving HSCs vigourously cycle to reconstitute
haematopoiesis. Enhanced replicative stress promotes their
ageing and mutation rates gradually increase. Random mutations
thus accumulate in HSCs during repeated replications unless
the mutations bring on a loss of stem cell function. If a
leukaemia-specific mutation occurs in an Sfpi1-hemizygous cell
in due course, the cell becomes a leukaemic stem cell. As the
leukaemic stem cells can arise not only from HSCs, but also
from CMPs and GMPs (Passegue ´ and Weisman, 2005), those
outnumbering cells are more likely to be the origin of AMLs
if the elevated mutation rates of HSCs are inherited by the
progeny. Although the model does not exclude the possibility
that the deletion of chromosome 2 arises from delayed instability,
it is more reasonable to presume an early formation of the
aberration unless the spontaneous mutation rates increase
enormously.
According to this model, the induction pattern of AML could be
modified by changing the cell kinetics of haematopoietic cells. For
example, the latency of AML development will be longer and the
lifetime incidence will decrease if cycling rates of HSCs are slowed
down after irradiation. This has actually been showed by dietary
restriction in mice. Under caloric restriction, the cycling fraction
of haematopoietic stem/progenitor cells is low (Yoshida et al,
2006) and senescence of HSCs is postponed (Chen et al, 2003).
When exposed to radiation, those mice show a delayed onset and
lower incidence of AML compared with mice without caloric
restriction (Yoshida et al, 1997). Moreover, onset delay and
significant decrease in incidence are not observed in mice with
pre-irradiation restriction, but only with post-irradiation restric-
tion (Yoshida et al, 2006). All these findings are consistent with the
proposed model.
Finally, we should note the limitations of our mathematical
analysis. We consulted the literature for realistic parameter values,
but available data were limited and arbitrary values had to be
assigned to some parameters. In addition, there are factors not
taken into account in the analysis; that is spontaneous cell death/
inactivation, cell kinetics change because of natural ageing, strain
difference in cell kinetics, and radiation effects on stromal cells.
Self-
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Figure 8 Schematic of proposed model for radiation-induced murine AML. HSCs that escape death by radiation vigourously cycle to reconstitute
haematopoiesis. Some of them carry a deletion of chromosome 2, being hemizygous for the Sfpi1 gene. Enhanced replicative stress promotes ageing of
HSCs and the mutation rates gradually increase. On repeated cell divisions with elevated mutation rates, the progeny (CMP or GMP) of an Sfpi1-hemizygous
HSC spontaneously acquire the AML-specific Sfpi1 mutation to become a leukaemic stem cell.
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simulation integrating those factors. However, despite these
limitations, it is certain that surviving HSCs have to cycle at
enhanced rates to recover and maintain haematopoiesis after
irradiation. We therefore conclude that the acceleration of HSC
ageing because of continuous replicative stress is a major effect of
irradiation in murine leukaemogenesis.
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